Dedicated to Neurological Discoveries
PRESCRIBING INFORMATION
QUALITATIVE AND QUANTITATIVE COMPOSITION Per Vial: Clostridium botulinum type A toxin-haemagglutinin complex: 500U. Albumin solution:125MCG. Lactose:2.5MG
PHARMACEUTICAL FORM Injection.
CLINICAL PARTICULARS Therapeutic indications: Dysport® is indicated for the following treatments: Adults Arm Spasticity following a stroke, Dynamic equines foot deformity due to spasticity in ambulant paediatric cerebral palsypatients, two years of age or older, only in hospital specialist centres with appropropriately trained personnel, Spasmodic torticollis in adults, Blepharospasm in adults, and Hemifacial spasm in adults.
Indications and dosages may vary from country to country. Please refer to local product insert for more information.
